COA 203089 matches Janoshik Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
The portal confirms the certificate. It can't show that a vial you buy from the shop is from this batch — compare the lot on yours.
TJENVUHP4F11Not on file for this certificate: endotoxins, sterility and heavy metals. A purity figure says nothing about those.
Label 30 mg · Lab measured 34.45 mg
115% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 8.6 mg using the measured mass, against 7.5 mg on the label — 15% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | 203089 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | Janoshik Labs's portal shows validity only |
| Weight | Listed for information — supplier-provided, not counted |
HPLC purity analysis of Tirzepatide, ordered by the selling shop's supplier and performed by Janoshik Labs on July 27, 2026. Reported purity: 99.772%. Net content: 34.45 mg against 30 mg labeled (115% of label). Tested content exceeds the labeled amount by 15%. Batch RT30-061526. Sample source: supplier-provided. Certificate of analysis attached.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion